Connor L. Trotter

Connor L. Trotter

Auto-generated profile, based on publicly available information

Connor L. Trotter

Institute of Quantitative Biology, Biochemistry and Biotechnology, School of Biological Sciences, University of Edinburgh, Edinburgh, UK

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2023 in Trends in Biotechnology
Verified
Journal Article
Open access
CTConnor L. Trotter
Connor L. Trotter
GBGautham S. Babu
Gautham S. Babu
SWStephen Wallace
Stephen Wallace
Over the past decade, numerous approaches have been taken to replace unsustainable chemical syntheses with green biosynthetic alternatives. In a landmark paper, Yim et al. utilised an in silico-to-in vivo workflow to enable the high-level bioproduction of the unnatural small molecule 1,4-butanediol in the bacterium Escherichia coli.

16 March 2026 in Nature Sustainability
Verified
Journal Article
Open access
PDF file
BRBenjamin Royer
Benjamin Royer
YEYuta Era
Yuta Era
MVMarcos Valenzuela-Ortega
Marcos Valenzuela-Ortega
TTThomas W. Thorpe
Thomas W. Thorpe
CTConnor L. Trotter
Connor L. Trotter
SWStephen Wallace
Stephen Wallace
Using engineering biology to perform complex chemical synthesis offers a sustainable alternative to traditional processes that rely on finite fossil resources. A growing opportunity within this field lies in reclaiming carbon embedded in industrial and post-consumer waste—carbon otherwise lost to landfill, incineration or pollution. Here we report the bio-upcycling of poly(ethylene terephthalate) (PET) plastic waste into levodopa ( l -DOPA), a frontline medication for Parkinson’s disease, using engineered Escherichia coli . Two key bottlenecks—substrate import and feedback inhibition by the intermediate protocatechuate—were addressed through heterologous transporter expression and functional pathway separation across two microbial strains. To further improve sustainability, and as a proof-of-concept, Chlamydomonas reinhardtii was used to capture CO 2 released during catechol generation. The resulting bioprocess operates under mild, aqueous conditions and achieves high l -DOPA titres (5.0 g l −1 ), with isolated product obtained at preparative scale from both industrial PET waste and a single post-consumer plastic bottle. This work demonstrates how engineering biology can transform plastic-derived aromatic monomers into high-value pharmaceuticals for the treatment of neurological disease in humans.

29 January 2026 in Nature Reviews Clean Technology
Verified
Journal Article
Closed access
PDF file
CTConnor L. Trotter
Connor L. Trotter
KCKitty Clouston
Kitty Clouston
JSJohn F. C. Steele
John F. C. Steele
LMLouis Marlow
Louis Marlow
SWStephen Wallace
Stephen Wallace

10 July 2024 in ChemRxiv
Verified
Preprint
Open access
PDF file
CTConnor Trotter
Connor Trotter
RGRory Gordon
Rory Gordon
SLSamantha Law
Samantha Law
SWStephen Wallace
Stephen Wallace
Microbial metabolism is a diverse and sustainable source of synthetic reagents that can be programmed for controlled and high-level production via synthetic biology. However, despite the chemical diversity of metabolism, the chemical utility of metabolites, and the available tools to control metabolic chemistry, there remain few examples of the use of cellular metabolites directly for chemical synthesis. Herein we report that diverse bacteria perform P=S bond formation (Ph3P to Ph3PS) via central sulfur metabolism and non-enzymatic chemistry in vivo and can also be applied to effect microbial P=Se bond formation (Ph3PSe). To the best of our knowledge, this is the first biochemical and genetic investigation of P=S bond formation in a microbial cell and the first use of microbial metabolites for P=Se bond formation in chemical synthesis.